What is Simulations Plus Inc (SLP)?
Simulations Plus Inc develops software solutions and provides consulting services for the pharmaceutical and biotechnology industries. The company specializes in modeling and simulation tools that support drug discovery, development, and regulatory submissions. Its products assist in predicting pharmacokinetics, pharmacodynamics, and toxicology profiles of drug candidates. Simulations Plus offers computational platforms that enable researchers to optimize drug formulations and dosing regimens. The company also provides scientific consulting to enhance drug development strategies and regulatory compliance. Operating within the life sciences and software sectors, Simulations Plus contributes to improving the efficiency and success rates of pharmaceutical research through advanced computational methodologies.
Simulations Plus Inc Stock Price Today: Live Overview
The price today is shaped by current trading trends, with Simulations Plus Inc at $11.71. It has moved in the range from $11.31 to $11.65, reflecting a daily percentage change of 0%.
FAQ: Simulations Plus Inc (SLP)
What is the current price of SLP stock?
The current price is $11.71.
Does SLP pay dividends?
Dividends are not paid by Simulations Plus Inc.
Does SLP have a formal corporate presence or regional headquarters in the UAE?
Simulations Plus Inc does not have an official presence in the UAE and operates through partners.
What is SLP best known for?
It is most famous for software and consulting services in pharmaceutical modeling and simulation.
What assets are typically shown together with SLP?
Commonly shown alongside SLP: State Street SPDR S&P 400 Mid Cap Value ETF, Omnicell Inc, Global X Artificial Intelligence & Technology ETF
Latest shares articles



